A case of assisted reproductive technology–induced maternal alloimmunization: an emerging sensitizing factor to consider? Cover

.blurhash-client-img { display: none !important; }

A case of assisted reproductive technology–induced maternal alloimmunization: an emerging sensitizing factor to consider?

Immunohematology

Volume 40 (2024): Issue 4 (December 2024)

By: Deepti Sachan, Varnisha Thiyagarajan and Deepthi Krishna G

Open Access

|Dec 2024

Authors

Deepti Sachan

deepti.vij@gmail.com

Rela Institute & Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India

Varnisha Thiyagarajan

Rela Institute & Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India

Deepthi Krishna G

Rela Institute & Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India

DOI: https://doi.org/10.2478/immunohematology-2024-020 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X

Journal RSS Feed

Language: English

Page range: 149 - 152

Published on: Dec 31, 2024

Published by: American National Red Cross

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

assisted reproductive technology (ART),

ART-induced maternal alloimmunization (AIMA),

ABO discrepancy,

red cell sensitization,

in vitro fertilization,

Related subjects:

Clinical medicine,

Laboratory medicine

© 2024 Deepti Sachan, Varnisha Thiyagarajan, Deepthi Krishna G, published by American National Red Cross
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 40 (2024): Issue 4 (December 2024)Next article